- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06599879
Bestråling i pædiatri: neurokognition, neuroimaging og evaluering af hukommelse og opmærksomhed (IPANEMA)
This is a prospective, open-label, multicentric study designed to correlate the dose delivered to the hippocampus with declarative memory deficits 2 years after radiotherapy treatment in a paediatric population who had received brain irradiation between the ages of 4 and 12 for a brain tumour.
In order to meet this objective, several neuropsychological assessments consisting of parental questionnaires and cognitive tests will be carried out during the course of the study, at the following two stages:
- A 1st assessment at patient inclusion, i.e. 2 years after the end of radiotherapy treatment,
- And a second assessment 2 years after patient inclusion, i.e. 4 years after the end of radiotherapy treatment.
A retrospective assessment of the patient's neurocognitive level 1 year before the diagnosis of the disease will also be carried out at inclusion, with the parents completing a questionnaire specifically designed for the trial.
In addition, patients who have received their radiotherapy treatment at the IUCT-O will be offered participation in the ancillary imaging study. If the parents and the patient agree, multimodal MRI scans specific to the study (without injection of contrast) will be performed at inclusion and 2 years after inclusion.
Imaging and radiotherapy data will be collected in parallel using the PediaRT software used in current practice (collection of radiotherapy dosimetric data as well as standard MRI examinations pre-operatively, post-operatively, and at the 2-year and 4-year follow-up).
130 patients will be included in this study.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Anne LAPRIE
- Telefonnummer: 05 31 15 54 43
- E-mail: laprie.anne@iuct-oncopole.fr
Studiesteder
-
-
-
Angers, Frankrig
- Rekruttering
- CHU Angers
-
Kontakt:
- Claire BRISSET
- Telefonnummer: 02 41 35 65 24
- E-mail: Claire.brisset@chu-angers.fr
-
Bordeaux, Frankrig
- Rekruttering
- CHU de Bordeaux
-
Kontakt:
- Aymeri HUCHET
- Telefonnummer: 05 57 62 33 00
- E-mail: aymeri.huchet@chu-bordeaux.fr
-
Caen, Frankrig
- Rekruttering
- Centre François Baclesse
-
Kontakt:
- Jordan BOUTER
- Telefonnummer: 02 31 45 50 50
- E-mail: j.bouter@baclesse.unicancer.fr
-
Lille, Frankrig
- Ikke rekrutterer endnu
- Centre Oscar Lambret
-
Kontakt:
- Xavier MIRABEL
- Telefonnummer: 03 20 29 59 11
- E-mail: x-mirabel@o-lambret.fr
-
Lyon, Frankrig
- Rekruttering
- Centre Léon Bérard
-
Kontakt:
- Cécile FAURE-CONTER
- Telefonnummer: 04 78 78 59 58
- E-mail: cecile.conter@ihope.fr
-
Marseille, Frankrig
- Rekruttering
- APHM - Hôpital la Timone
-
Kontakt:
- Xavier MURRACIOLE
- Telefonnummer: 04 91 38 43 34
- E-mail: xavier.muracciole@ap-hm.fr
-
Montpellier, Frankrig
- Ikke rekrutterer endnu
- Institut du Cancer de Montpellier
-
Kontakt:
- Marie CANTALOUBE
- Telefonnummer: 04 67 61 45 25
- E-mail: marie.cantaloube@icm.unicancer.fr
-
Paris, Frankrig
- Ikke rekrutterer endnu
- Institut Curie
-
Kontakt:
- Emmanuel JOUGLAR
- Telefonnummer: 01 44 32 46 25
- E-mail: emmanuel.jouglar@curie.fr
-
Rennes, Frankrig
- Rekruttering
- Centre Eugène Marquis
-
Kontakt:
- Loïg DUVERGE
- Telefonnummer: 02 99 25 30 92
- E-mail: l.duverge@rennes.unicancer.fr
-
Saint-Herblain, Frankrig
- Ikke rekrutterer endnu
- Institut de Cancérologie de l'Ouest
-
Kontakt:
- Gaëlle LE QUELLENEC
- Telefonnummer: 02 40 67 99 00
- E-mail: gaelle.lequellenec@ico.unicancer.fr
-
Strasbourg, Frankrig
- Rekruttering
- Centre Paul Strauss
-
Kontakt:
- Georges NOEL
- Telefonnummer: 03 68 76 69 69
- E-mail: g.noel@icans.eu
-
Toulouse, Frankrig
- Rekruttering
- IUCT-O
-
Kontakt:
- Anne LAPRIE
- Telefonnummer: 05 31 15 54 43
- E-mail: laprie.anne@iuct-oncopole.fr
-
Vandœuvre-lès-Nancy, Frankrig
- Rekruttering
- Institut de Cancérologie de Lorraine
-
Kontakt:
- Maria JOLNEROVSKI
- Telefonnummer: 03 83 59 84 27
- E-mail: m.jolnerovski@nancy.unicancer.fr
-
Villejuif, Frankrig
- Rekruttering
- Institut Gustave Roussy
-
Kontakt:
- Noura SELLAMI
- Telefonnummer: 01 42 11 55 42
- E-mail: noura.sellami@gustave.fr
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patient who has received localised brain irradiation or craniospinal irradiation for a brain tumour whose treatment includes first-line radiotherapy.
- Patient with one of the following tumour types: ependymomas, medulloblastomas, malignant germ cell tumours, craniopharyngioma, pinealoblastoma.
- Patient aged between 4 and 12 years at the time of radiotherapy treatment.
- End of irradiation within 2 years (+/-3 months) prior to inclusion.
- Patient having been treated by photontherapy or proton therapy.
- Sufficient visual, auditory (with authorised hearing aid) and oral or written expression capacity to carry out the neuropsychological tests properly.
- Proficiency in the French language by the patient and parent(s).
- Patient affiliated to a Social Security scheme in France.
- Informed consent signed by the patient/legal parent(s)/guardian(s) in accordance with French law and Good Clinical Practice.
Exclusion Criteria:
- Patient presenting with severe ataxia.
- Patient with a recurrence of the disease.
- Not applicable since protocol version 2. Metastatic patient.
- Any contraindication to MRI for patients included in Toulouse (i.e. in particular patients with a pacemaker or cardiac defibrillator, implanted equipment activated by an electrical, magnetic or mechanical system, patients with haemostatic clips on intracerebral aneurysms, patients with orthopaedic implants, claustrophobic patients).
- Patients undergoing psychostimulant or psychotropic treatment (in particular methylphenidate, antidepressants).
- Any psychological, family, geographical or sociological condition that prevents compliance with medical monitoring and/or the procedures set out in the study protocol.
- Patients deprived of their liberty or under legal protection.
- Severe posterior fossa syndrome with akinetic mutism.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: Patienter med en hjernetumor behandlet med strålebehandling i første linje 2 år før inklusion.
|
Several neuropsychological assessments were carried out during the study (at inclusion and 2 years after inclusion), consisting of :
Only for patients having received their radiotherapy treatment at the IUCT-O: a multimodal MRI specific to the study (without injection of contrast product) may be performed at inclusion and 2 years after inclusion. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Et underskud af den deklarative hukommelse vil blive defineret ved en standardscore på Children's Memory Scale (CMS) ≤ 5
Tidsramme: 24 måneder for hver patient
|
24 måneder for hver patient
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Deklarativ hukommelse vil blive vurderet ved hjælp af den tilpassede EPIREAL test.
Tidsramme: 24 måneder for hver patient
|
24 måneder for hver patient
|
|
|
Deklarativ hukommelse vil blive vurderet ved det selvbiografiske hukommelsesspørgsmål.
Tidsramme: 24 måneder for hver patient
|
24 måneder for hver patient
|
|
|
Underskuddet af den proceduremæssige hukommelse vil blive defineret af en score på mindre end eller lig med 10/20 på de sidste 20 forsøg (ud af 50) af den probabilistiske klassifikationsopgave.
Tidsramme: 24 måneder for hver patient
|
24 måneder for hver patient
|
|
|
Underskuddet af den proceduremæssige hukommelse vil blive defineret af en specifik indlæringsscore mindre end eller lig med nul af den tilpassede serielle reaktionstidsopgave (SRTT).
Tidsramme: 24 måneder for hver patient
|
24 måneder for hver patient
|
|
|
Working memory deficit will be defined if at least one of the two subtests (Number memory (WISC-V) and Spatial memory (WNV)) shows a deficit.
Tidsramme: 24 months for each patient
|
For each subtest, a deficit will be defined respectively by a standard score ≤ 5 and a percentile rank ≤ 5. |
24 months for each patient
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 24TETE01
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .